Carmel Murone

Ludwig Institute for Cancer Research, Austin Hospital, Heidelberg, Victoria, Australia

[ 1 ] - In vivo imaging of cellular proliferation in renal cell carcinoma using 18F-fluorothymidine PET

Objective(s): The ability to measure cellular proliferation non-invasively in renal cell carcinoma may allow prediction of tumour aggressiveness and response to therapy. The aim of this study was to evaluate the uptake of 18Ffluorothymidine (FLT) PET in renal cell carcinoma (RCC), and to compare this to 18F-fluorodeoxyglucose (FDG), and to an immunohistochemical measure of cellular proliferatio...

نویسندگان همکار